Komori
Olympus (7733) · InitiativeAdvanced

Separate Presentation of Sales in Light of the Importance of the Chinese Market

First written in FY2020-Q1. 4 of 5 entries say "Advanced", first in FY2020. Latest entry: FY2025.

5entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020-Q1AdvancedFY2020 – FY20252019: 120192020: 120202021: 020212022: 020222023: 120232024: 120242025: 12025
Same theme, other companies
Separate Regional Classification for North American SalesA theme 16 companies write about · 0 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 1 of 6 companies on the "Worse" side.

1 other company's latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 16 companies compared. The sentences above are computed from all 16.
Full recordFilings, disclosures and news, newest first
  1. FY2025AdvancedAnnual report

    「The Company is also accelerating measures to establish a local production site in China and provide products manufactured in China for the Chinese market.」

    Regarding the Chinese market, the Company is accelerating the establishment of a local production site in China, in addition to education and training and needs exploration.
  2. FY2024AdvancedAnnual report

    「Core gastrointestinal endoscopy system EVIS X1: launched in Europe, Asia and Japan in the fiscal year ending March 2021, and in the United States and China in the fiscal year ending March 2024.」

    In light of the importance of the Chinese market, the Company launched EVIS X1 in the United States and China and began preparing a local production site in China.
  3. FY2023AdvancedAnnual report

    「The Company is also preparing a local production site in China and considering providing products manufactured in China for the Chinese market.」

    In light of the importance of the Chinese market, the Company is preparing a local production site in China, in addition to investing in education and training and exploring unmet needs.
  4. FY2020AdvancedAnnual report

    「As the importance of the Chinese market has increased, revenue from China, which was previously included in “Asia and Oceania,” has been presented separately from the current consolidated fiscal year.」

    The separate presentation of revenue from China continued in the full-year disclosure, with revenue from China increasing to ¥103.036 billion year on year.
  5. FY2020-Q1First statedAnnual report

    「As the importance of the Chinese market has increased, revenue from China, which was previously included in “Asia and Oceania,” has been presented separately from the first quarter of the current consolidated fiscal year.」

    In response to the growing importance of the Chinese market, revenue from China was separately disclosed from Asia and Oceania in regional revenue reporting from FY2020-Q1.
Moved together

"Global Compliance Management System" moved the same way as this thread, in the same document, in 4 of its 5 moves.

444444★123456
  1. ★This thread
  2. 1Global Compliance Management System4×
  3. 2Establishment of a Company-Wide Quality Management System4×
  4. 3Further expansion of operations centered on the healthcare business4×
  5. 4Maintaining Competitiveness in Gastrointestinal Endoscopy and Growing the Treatment Device and Surgical Businesses4×
  6. 5Continued strengthening of core technologies centered on healthcare4×
  7. 6Active Investment in the Medical Business and Expansion of Growth Areas4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Olympus yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Separate Presentation of Sales in Light of the Importance of the Chinese Market | OLYMPUS CORPORATION (7733) | Komori